CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 85 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2018. The put-call ratio across all filers is 3.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $480,769,000 | +50.3% | 4,199,958 | +25.1% | 0.16% | +54.9% |
| Q2 2019 | $319,971,000 | +84.4% | 3,357,517 | +76.6% | 0.10% | +85.5% |
| Q1 2019 | $173,503,000 | +9.5% | 1,901,400 | -8.9% | 0.06% | 0.0% |
| Q4 2018 | $158,451,000 | -35.0% | 2,087,348 | -31.5% | 0.06% | -22.5% |
| Q3 2018 | $243,823,000 | -33.1% | 3,047,782 | -16.9% | 0.07% | -29.0% |
| Q2 2018 | $364,366,000 | +13.1% | 3,668,237 | -7.7% | 0.10% | +8.7% |
| Q1 2018 | $322,049,000 | +24.6% | 3,975,908 | +21.2% | 0.09% | +21.1% |
| Q4 2017 | $258,442,000 | -14.5% | 3,280,964 | +0.1% | 0.08% | -16.5% |
| Q3 2017 | $302,372,000 | -18.1% | 3,277,039 | +0.4% | 0.09% | -21.6% |
| Q2 2017 | $369,236,000 | – | 3,264,683 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 131,657 | $13,077,000 | 5.92% |
| Point72 Hong Kong Ltd | 103,797 | $10,310,000 | 3.49% |
| York Capital Management Global Advisors, LLC | 827,738 | $82,219,000 | 2.00% |
| Parametrica Management Ltd | 3,889 | $386,000 | 1.83% |
| Athos Capital Ltd | 35,266 | $3,503,000 | 1.19% |
| Hillhouse Capital Management | 618,391 | $61,425,000 | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 502,812 | $49,940,000 | 0.73% |
| Black Creek Investment Management Inc. | 240,232 | $23,862,000 | 0.73% |
| COMGEST GLOBAL INVESTORS S.A.S. | 243,652 | $24,202,000 | 0.54% |
| Temasek Holdings (Private) Ltd | 990,000 | $98,337,000 | 0.52% |